Emerging intelligent wearable devices for cardiovascular health monitoring

IF 13.2 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY Nano Today Pub Date : 2024-11-08 DOI:10.1016/j.nantod.2024.102544
Yiqian Wang , Yang Zou , Zhou Li
{"title":"Emerging intelligent wearable devices for cardiovascular health monitoring","authors":"Yiqian Wang ,&nbsp;Yang Zou ,&nbsp;Zhou Li","doi":"10.1016/j.nantod.2024.102544","DOIUrl":null,"url":null,"abstract":"<div><div>Cardiovascular diseases have long posed a significant threat to human health. Wearable devices are increasingly vital in cardiovascular health monitoring, disease screening, and early warning because of their non-invasiveness, real-time data provision and continuous monitoring capability. The collection, processing, and analysis of data in cardiovascular health monitoring involve numerous repetitive and standardized tasks, where artificial intelligence (AI) technology plays a pivotal role. AI is particularly effective in handling large volumes of data, thus enhancing the diagnostic and predictive capabilities of wearable devices. This review summarizes essential indicators for assessing cardiovascular health and provides a comprehensive introduction to commonly used non-invasive monitoring methods, including pulse pressure, photoplethysmography, electrocardiogram, bioimpedance analysis, seismocardiography/ ballistocardiography, and ultrasonography. Additionally, some impressive advances in wearable cardiovascular health monitoring technologies are reviewed and their integration with AI is highlighted, demonstrating typical application cases from recent years. Finally, the review discusses the current challenges of integrating AI into wearable devices for cardiovascular health monitoring, focusing on aspects from device design, algorithm optimization, comfort, reliability, and security. With the seamless integration of AI and wearable devices, a new generation of wearable intelligent devices promises to revolutionize the monitoring, prevention and management strategies of cardiovascular diseases.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"59 ","pages":"Article 102544"},"PeriodicalIF":13.2000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nano Today","FirstCategoryId":"88","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1748013224004006","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Cardiovascular diseases have long posed a significant threat to human health. Wearable devices are increasingly vital in cardiovascular health monitoring, disease screening, and early warning because of their non-invasiveness, real-time data provision and continuous monitoring capability. The collection, processing, and analysis of data in cardiovascular health monitoring involve numerous repetitive and standardized tasks, where artificial intelligence (AI) technology plays a pivotal role. AI is particularly effective in handling large volumes of data, thus enhancing the diagnostic and predictive capabilities of wearable devices. This review summarizes essential indicators for assessing cardiovascular health and provides a comprehensive introduction to commonly used non-invasive monitoring methods, including pulse pressure, photoplethysmography, electrocardiogram, bioimpedance analysis, seismocardiography/ ballistocardiography, and ultrasonography. Additionally, some impressive advances in wearable cardiovascular health monitoring technologies are reviewed and their integration with AI is highlighted, demonstrating typical application cases from recent years. Finally, the review discusses the current challenges of integrating AI into wearable devices for cardiovascular health monitoring, focusing on aspects from device design, algorithm optimization, comfort, reliability, and security. With the seamless integration of AI and wearable devices, a new generation of wearable intelligent devices promises to revolutionize the monitoring, prevention and management strategies of cardiovascular diseases.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于心血管健康监测的新兴智能可穿戴设备
长期以来,心血管疾病一直对人类健康构成重大威胁。可穿戴设备因其非侵入性、实时数据提供和持续监测能力,在心血管健康监测、疾病筛查和早期预警方面发挥着越来越重要的作用。心血管健康监测中的数据收集、处理和分析涉及大量重复性和标准化的任务,人工智能(AI)技术在其中发挥着举足轻重的作用。人工智能在处理大量数据方面尤为有效,从而提高了可穿戴设备的诊断和预测能力。本综述总结了评估心血管健康的基本指标,并全面介绍了常用的无创监测方法,包括脉压、光电血压计、心电图、生物阻抗分析、地震心动图/弹道心动图和超声波检查。此外,还回顾了可穿戴心血管健康监测技术的一些令人印象深刻的进展,并重点介绍了这些技术与人工智能的结合,展示了近年来的典型应用案例。最后,综述讨论了当前将人工智能集成到心血管健康监测可穿戴设备中的挑战,重点关注设备设计、算法优化、舒适性、可靠性和安全性等方面。随着人工智能与可穿戴设备的无缝整合,新一代可穿戴智能设备有望彻底改变心血管疾病的监测、预防和管理策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nano Today
Nano Today 工程技术-材料科学:综合
CiteScore
21.50
自引率
3.40%
发文量
305
审稿时长
40 days
期刊介绍: Nano Today is a journal dedicated to publishing influential and innovative work in the field of nanoscience and technology. It covers a wide range of subject areas including biomaterials, materials chemistry, materials science, chemistry, bioengineering, biochemistry, genetics and molecular biology, engineering, and nanotechnology. The journal considers articles that inform readers about the latest research, breakthroughs, and topical issues in these fields. It provides comprehensive coverage through a mixture of peer-reviewed articles, research news, and information on key developments. Nano Today is abstracted and indexed in Science Citation Index, Ei Compendex, Embase, Scopus, and INSPEC.
期刊最新文献
Natural-based UV-shielding additives to protect photosensitive pesticides: Production of nanoparticles from the co-self-assembly of lignin and tannin In situ atomic observation of transformation twinning in nanocrystals Energy-based surgery generated carbonized particles promote the development of ovarian cancer Adipose tissue targeted sequential delivery system regulating glycolipid metabolism for systemic obesity and its comorbidities CD33 targeted EzH1 regulated nanotherapy epigenetically inhibits fusion oncoprotein (AML1-ETO) rearranged acute myeloid leukemia in both in vitro and in vivo Patient Derived Xenograft models
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1